Board of Directors
Mr. Huang has held major positions in various holding companies and was appointed as an MBA master tutor for the Business School of Hunan Normal University. He brought back a nearly bankrupt company to the capital market and was responsible for a 15-fold stock price increase and a 26 billion CNY increase in market value.
In 2005, he won the "1st Top Ten Charity Enterprise Award" in the Hunan Province, China. In 2006, won the "Top 10 Outstanding Youth Award in Hunan Province".
MR. HUANG QINGXI
CHAIRMAN OF BOARD OF DIRECTORS, PRESIDENT
Prof. Chaim Lotan completed medical training at the Hebrew University Hadassah Medical School in 1979 and concluded his specialization in Cardiology in 1987. In 1996 he was appointed Director of Interventional Cardiology and Cardiac Catheterization in Hadassah Medical Center in Jerusalem. In 2009 he received the appointment of Professor of Medicine (Cardiology) from The Hebrew University of Jerusalem Faculty of Medicine. Prof. Lotan has been involved in a number of biomedical innovative ventures and serves as Medical Officer/Advisor in several medical technology companies in the fields of cardiology and imaging.
PROF. CHAIM LOTAN
CPA as senior accountant at KPMG Israel. Mr. Dvir has a BA and MBA in Business Administration from the College of Management and brings fifteen years of international experience in the fields of finance & legal.
He has served as the CFO of Q Core Medical since 2010 and of a group of 3 affiliates companies since 2016 and is a former controller at Gilat Satellite Ltd. He served six years at IBM in the finance department in several positions including controller and cost accountant at IBM Israel.
MR. BARAK DVIR
CEO of China-Israel Biological Technology Co. Based in Israel since 2013, Mr. Zhang is a private investor who worked as a financial advisor to major Chinese private equity funds regarding investments in Israel. He also served as a senior VP and general counsel of Avantalion, as well as General Counsel of CA Investment Company. Mr. Zhang has also participated in many Chinese-state-owned companies listed in New York.